The DSM-5 cannabis use disorder diagnosis holds up well, especially for severe cases
The DSM-5 definition of cannabis use disorder and its severity levels were supported by their associations with cannabis use patterns, psychiatric disorders, and social impairment, with severe CUD showing the strongest validity.
Quick Facts
What This Study Found
DSM-5 CUD and all severity levels were associated with cannabis use validators (days used, self-reported problem use, craving). Severe CUD was additionally associated with other psychiatric disorders and social impairment. Mild and moderate CUD were associated only with cannabis-specific validators, supporting them as clinically distinct from severe CUD.
Key Numbers
392 past-year cannabis users. Severe CUD associated with validators across all domains (cannabis use, psychiatric, social). Mild and moderate CUD associated with cannabis-specific validators only.
How They Did This
Study of 392 past-year cannabis users with problematic substance use recruited from a research setting and an inpatient treatment program. Semi-structured clinician-administered diagnostic interviews assessed DSM-5 CUD. Regression models tested associations with validators across cannabis use, psychopathology, and functional impairment domains.
Why This Research Matters
The DSM-5 changed how cannabis use disorder is diagnosed (combining abuse and dependence, adding withdrawal and craving). Validating these changes ensures clinicians are using a meaningful diagnostic framework.
The Bigger Picture
The distinction between severity levels has practical implications: severe CUD likely requires intensive treatment addressing psychiatric and social functioning, while mild/moderate CUD may benefit from prevention and brief intervention.
What This Study Doesn't Tell Us
Sample recruited from clinical and research settings, not the general population. Cross-sectional design cannot assess predictive validity. Predominantly problematic substance users.
Questions This Raises
- ?Do mild and moderate CUD predict progression to severe CUD over time?
- ?Would severity-matched treatments improve outcomes?
Trust & Context
- Key Stat:
- Severe CUD linked to psychiatric disorders and social impairment; mild/moderate were not
- Evidence Grade:
- Clinician-administered diagnostic interviews with appropriate validators, but clinical sample limits generalizability.
- Study Age:
- Published in 2022.
- Original Title:
- Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.
- Published In:
- Journal of psychiatric research, 155, 387-394 (2022)
- Authors:
- Fink, David S(13), Shmulewitz, Dvora(4), Mannes, Zachary L(10), Stohl, Malka, Livne, Ofir, Wall, Melanie, Hasin, Deborah S
- Database ID:
- RTHC-03842
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
What changed from DSM-IV to DSM-5 for cannabis disorders?
DSM-5 combined the old "abuse" and "dependence" categories into a single "cannabis use disorder" with severity levels (mild, moderate, severe), removed the legal criterion, and added cannabis withdrawal and craving as new criteria.
When does cannabis use disorder become "severe"?
Severe CUD was distinguished from mild/moderate by its associations with other psychiatric disorders and social impairment, suggesting it represents a qualitatively different condition requiring more intensive treatment.
Read More on RethinkTHC
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-use-disorder-test
- cross-addiction-quit-weed-start-drinking
- is-weed-addictive
- is-weed-addictive-science
- quitting-weed-and-alcohol
- rehab-for-weed-addiction-necessary
- signs-of-cannabis-use-disorder
- weed-vape-pen-addiction
Cite This Study
https://rethinkthc.com/research/RTHC-03842APA
Fink, David S; Shmulewitz, Dvora; Mannes, Zachary L; Stohl, Malka; Livne, Ofir; Wall, Melanie; Hasin, Deborah S. (2022). Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.. Journal of psychiatric research, 155, 387-394. https://doi.org/10.1016/j.jpsychires.2022.09.016
MLA
Fink, David S, et al. "Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.." Journal of psychiatric research, 2022. https://doi.org/10.1016/j.jpsychires.2022.09.016
RethinkTHC
RethinkTHC Research Database. "Construct validity of DSM-5 cannabis use disorder diagnosis ..." RTHC-03842. Retrieved from https://rethinkthc.com/research/fink-2022-construct-validity-of-dsm5
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.